Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations

SIMPLE SUMMARY: Cholangiocarcinoma (CCA) is a cancer arising from the bile ducts. Chemotherapy has long been the standard of care for metastatic CCA, but recent clinical trials have shown that fibroblast growth factor receptor (FGFR) inhibitors are a promising new treatment in advanced CCA with docu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Patrick C., Hendifar, Andrew, Osipov, Arsen, Cho, May, Li, Daneng, Gong, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038487/
https://www.ncbi.nlm.nih.gov/pubmed/33916849
http://dx.doi.org/10.3390/cancers13071706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038487/
https://www.ncbi.nlm.nih.gov/pubmed/33916849
http://dx.doi.org/10.3390/cancers13071706

Ejemplares similares